Advanced Malignant Tumors Clinical Trial
Official title:
Phase I Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors
TQB3617 is a bromodomain and extra-terminal (BET) inhibitor that can competitively bind to bromodomains (BRDs) with Acetylated lysine(Kac) and block or partially block the role of KAc in subsequent gene transcription and regulation of chromatin structure, thereby playing an anti-tumor role.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05082545 -
Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT04128085 -
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05229497 -
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06223841 -
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05728541 -
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05354076 -
Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
|
Phase 2 | |
| Recruiting |
NCT05868876 -
A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05991583 -
A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05396391 -
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05235542 -
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05214482 -
A Study of AK112 in Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05653284 -
A Study of AK130 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05223231 -
Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT05198817 -
A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients
|
Phase 1 | |
| Active, not recruiting |
NCT05193721 -
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT06226363 -
Phase I Study of LNF1901 in Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT06167486 -
SG2918 For Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT04980690 -
Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05877924 -
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
|
Phase 1 | |
| Active, not recruiting |
NCT04708210 -
Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors
|
Phase 1 |